BML Investment Partners, L.P. 13D and 13G filings for ARCA biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-07 1:08 pm Sale | 2023-12-31 | 13G | ARCA biopharma, Inc. ABIO | BML Investment Partners, L.P. | 58,911 4.900% | -12,611 (-17.63%) | Filing |
| 2023-02-08 2:48 pm Purchase | 2023-02-08 | 13G | ARCA biopharma, Inc. ABIO | BML Investment Partners, L.P. | 71,521 5.950% | 8,033 (+12.65%) | Filing |
| 2022-01-27 3:53 pm Purchase | 2022-01-24 | 13G | ARCA biopharma, Inc. ABIO | BML Investment Partners, L.P. | 63,488 5.300% | 63,488 (New Position) | Filing |